AdminiStration of Statin On Acute Ischemic stRoke patienT Trial

• Status: Completed
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Investigators will study whether immediate statin treatment after the onset of stroke is beneficial on the neurological protection

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hyogo College of Medicine
• Collaborator: Shionogi
• Treatments: Atorvastatin; Atorvastatin Calcium; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• the Informed consent will be acquired by the document.

• Age: 20 years of age or older.

• Gender: unquestioned

• hospitalization, outpatient: hospital

• Patients by MRI at the time of hospital transport, it has been confirmed diagnosed with cerebral infarction

• ingestible in within 24 hours after admission In the study treatment period, patients that can be defined treatment in this clinical study implementation plan

Exclusion Criteria:

• patients with a history of hypersensitivity to the treatment agent of the present study

• Patients acute hepatitis, chronic hepatitis acute exacerbation, liver cirrhosis, it is believed that the liver cancer, liver function jaundice or the like is reduced, or a biliary obstruction

• Patients suspected of being pregnant or pregnant

• Patients in the administration of the cyclosporine or telaprevir

• patients with moderate or severe renal impairment (SCr ≧ 2.5mg / dL or eGFR <30mg / dL)

• Patients who received a diagnosis of acute coronary syndrome within 6 months

• valvular disease, atrial fibrillation, patients with atrial thrombus

• Patients familial hypercholesterolemia

• patient admission NIHSS score is greater than or equal to 3 is more than 20 or before the onset mRS score

• patients with other doctors deemed inappropriate